INIFY — INIFY Laboratories AB Income Statement
0.000.00%
Last trade - 00:00- NOK273.68m
- NOK250.15m
- SEK13.13m
Annual income statement for INIFY Laboratories AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 14 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 1.19 | 13.1 |
| Cost of Revenue | |||
| Gross Profit | — | 0.852 | 11.3 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 44.6 | 57 | 66.1 |
| Operating Profit | -44.6 | -55.8 | -53 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | -44.2 | -53.3 | -51.6 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -44.2 | -53.3 | -51.6 |
| Net Income Before Extraordinary Items | |||
| Net Income | -44.2 | -53.3 | -51.6 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -44.2 | -53.3 | -51.6 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -1.28 | -1.18 | -1.14 |
| Dividends per Share |